KRAS and neoplasm: As shown in Table 2, the SUVmax had no significant associations with the TNM stage, clinical stage, vascular embolism, sex, differentiation degree, and KRAS mutation but was related to the tumor location (p = 0.003) and nerve invasion (p = 0.007).